Æterna Zentaris Денежные средства на акцию
Что обозначает Денежные средства на акцию в Æterna Zentaris?
Денежные средства на акцию Æterna Zentaris, Inc. является 11.08
Какое определение для Денежные средства на акцию?
Денежные средства на акцию - это наличные денежные средства компании, поделенные на акции компании в обращении.
Cash per share, sometimes called the cash share ratio, is the total cash per share. Cash on hand is reported on the balance sheet. Cash per share is calculated by dividing cash on hand by the total number of shares. Cash per share is the percentage of a firm's share price that is immediately accessible for spending. Cash per share consists of cash and short-term investments. It is money that a firm has on hand and does not come from borrowing or financing activities.
When a firm has a high cash per share, significant percentage of its assets is in a very liquid form. This can indicate economic uncertainty and unwillingness to invest given the current economic climate. High levels of cash per share can indicate that a firm is performing well and is able to reinvest in itself but high cash per share does not always indicate overall financial strength.
Денежные средства на акцию компаний в Health Care сектор на TSX по сравнению с Æterna Zentaris
Что делает Æterna Zentaris?
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as oncology indications. The company markets macimorelin under the Macrilen brand name. Aeterna Zentaris Inc. has a license agreement with University Wuerzburg to research, develop, manufacture, and sell a potential COVID-19 vaccine; development, manufacture, and commercialization of the treatment for neuromyelitis optica spectrum disorder; and to develop human 3D intestinal tissue models to study infection biology; and for pre-clinical development towards the potential treatment of Parkinson's disease. It also has a license agreement with Consilient Health Ltd., Novo Nordisk Novo Nordisk Health Care AG, and NK MEDITECH Ltd. for the development and commercialization of macimorelin in the United States and Canada, as well as The University of Sheffield, the United Kingdom for the research, development, manufacture, and commercialization of parathyroid hormone fusion polypeptides for the treatment of primary hypoparathyroidism. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina.
Компании с денежные средства на акцию похож на Æterna Zentaris
- Columbia Sportswear Co имеет Денежные средства на акцию из 11.07
- Gokaldas Exports имеет Денежные средства на акцию из 11.07
- Atlassian имеет Денежные средства на акцию из 11.07
- Beijing Bayi Space LCD Technology Co имеет Денежные средства на акцию из 11.07
- Goa Carbon имеет Денежные средства на акцию из 11.07
- ATCO имеет Денежные средства на акцию из 11.08
- Æterna Zentaris имеет Денежные средства на акцию из 11.08
- Arrow Greentech имеет Денежные средства на акцию из 11.09
- InspireMD Inc имеет Денежные средства на акцию из 11.10
- Almondz Global Securities имеет Денежные средства на акцию из 11.11
- PetIQ Inc имеет Денежные средства на акцию из 11.12
- SAF-HOLLAND SA имеет Денежные средства на акцию из 11.12
- Cann American имеет Денежные средства на акцию из 11.14